CVS Health (MEX:CVS) Research & Development: MXN0 Mil (TTM As of Mar. 2026)


MEX:CVS CVS Health Corp MEX:CVS
70 GF Score
Price MXN1,787.51
GF Value MXN1,326.88
Valuation Significantly Overvalued
! 10 Warning Signs
View Full Analysis

What is CVS Health Research & Development?

CVS Health MEX:CVS 70 Research & Development is MXN0 Mil as of Mar. 2026. GuruFocus rates MEX:CVS with a GF Score™ of 70/100 and a GF Value™ of MXN1,326.88 (Significantly Overvalued). The stock has 10 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. CVS Health's Research & Development for the three months ended in Mar. 2026 was MXN0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was MXN0 Mil.

CVS Health  (MEX:CVS) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

CVS Health Research & Development Related Terms

CVS Health Research & Development Historical Data

* Premium members only.

The historical data trend for CVS Health's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CVS Health Research & Development Chart

CVS Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CVS Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
MEX:CVS
70GF Score
CVS Health Corp MEX:CVS
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CVS Health Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of MXN0 Mil mean?
CVS Health (MEX:CVS) has a Research & Development of MXN0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on CVS Health and its competitors.
Is CVS Health's Research & Development too high?
CVS Health's current Research & Development is MXN0 Mil. Overall, CVS Health has a GF Score™ of 70/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does CVS Health's Research & Development compare to ELV and CI?
CVS Health's Research & Development of MXN0 Mil can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Plans company?
A good Research & Development depends on the Healthcare Plans industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on CVS Health and its competitors. CVS Health's current Research & Development is MXN0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CVS Health stock overvalued right now?
Based on GuruFocus' analysis, CVS Health (MEX:CVS) is currently considered Significantly Overvalued. The stock's GF Value™ is MXN1,326.88, compared to a current price of MXN1,787.51 — trading 34.7% above its estimated fair value. The current Research & Development is MXN0 Mil. CVS Health's overall GF Score™ is 70/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For CVS Health (MEX:CVS), the current Research & Development is MXN0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CVS Health (MEX:CVS) Overvalued in 2026?

Based on GuruFocus' analysis, CVS Health stock appears to be overvalued. The current stock price of MXN1,787.51 is trading 34.7% above its estimated GF Value™ of MXN1,326.88. GuruFocus considers CVS Health to be Significantly Overvalued.

Key valuation signals for MEX:CVS:

  • Research & Development: MXN0 Mil
  • GF Value™: MXN1,326.88 vs. price of MXN1,787.51 (34.7% above fair value)
  • GF Score™: 70/100 with 10 warning signs

No single metric tells the full story. See the MEX:CVS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CVS Health Business Description

Address One CVS Drive, Woonsocket, RI, USA, 02895
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
70GF Score

Get the complete analysis for MEX:CVS

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,787.51
Price
MXN1,326.88
GF Value